WELCOME TO The PHARMACEUTICAL REPORT
Home > Events >
Past Conferences >
September 11-13, 2019 | UK
Monoclonal antibody drugs (mAbs) make up more than 50
percent of the biologics on the market today, as well as a
significant number of new drugs in the development pipeline. The value and impact of these therapies has been dramatic.
March 23-24, 2023 | UK
March 20-21, 2023 | France
January 31-February 2, 2023 | UK
February 23-24, 2023 | USA
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE